- Article
Host Cell Proteins in Biologics Manufacturing: The Good, the Bad, and the Ugly
- Martin Kornecki,
- Fabian Mestmäcker,
- Steffen Zobel-Roos,
- Laura Heikaus de Figueiredo,
- Hartmut Schlüter and
- Jochen Strube
Significant progress in the manufacturing of biopharmaceuticals has been made by increasing the overall titers in the USP (upstream processing) titers without raising the cost of the USP. In addition, the development of platform processes led to a hi...